Treace John T. - 08 Mar 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Lisa Taylor as Attorney-in-fact for John T. Treace
Issuer symbol
TMCI
Transactions as of
08 Mar 2022
Net transactions value
$0
Form type
4
Filing time
10 Mar 2022, 19:24:32 UTC
Previous filing
30 Dec 2021
Next filing
24 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Award $0 +33,875 +0.62% $0.000000 5,456,455 08 Mar 2022 Direct F1, F2
holding TMCI Common Stock 1,605,000 08 Mar 2022 By Wife F4
holding TMCI Common Stock 1,471,250 08 Mar 2022 By Wife as cotrustee of the JTT Irrevocable Trust dated September 30, 2020 F4
holding TMCI Common Stock 1,839,063 08 Mar 2022 As Trustee of the Tracy W. Treace Irrevocable Trust dated September 25, 2020 F5
holding TMCI Common Stock 408,816 08 Mar 2022 As Co-Trustee of the John R. Treace Irrevocable Trust dated July 29, 2021 F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option (Right to Buy) Award $0 +240,566 $0.000000 240,566 08 Mar 2022 Common Stock 240,566 $19.15 Direct F3
transaction TMCI Stock Option (Right to Buy) Award $0 +20,884 $0.000000 20,884 08 Mar 2022 Common Stock 20,884 $21.06 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date.
F2 Includes 33,875 RSUs.
F3 The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.
F4 The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
F5 The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee.